These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2957473)

  • 1. Platelet deposition in rat heart allografts and the effect of a thromboxane receptor antagonist.
    Foegh ML; Khirabadi BS; Ramwell PW
    J Heart Transplant; 1986; 5(4):338-9. PubMed ID: 2957473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of experimental cardiac allograft survival with thromboxane-related drugs.
    Foegh ML; Khirabadi B; Ramwell PW
    Transplantation; 1985 Aug; 40(2):124-5. PubMed ID: 3161224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prednisolone, thromboxane, and platelet-activating factor receptor antagonists on lymphocyte and platelet migration in experimental cardiac transplantation.
    Khirabadi BS; Foegh ML; Goldstein HA; Ramwell PW
    Transplantation; 1987 May; 43(5):626-30. PubMed ID: 3033853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful experimental heart transplantation without immunosuppressive drugs.
    Kline GM; Shen Z; Mohiuddin M; Ruggiero V; Rostami S; DiSesa VJ
    J Heart Lung Transplant; 1993; 12(3):388-93. PubMed ID: 8329408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.
    Shen Z; Pelletier S; Mohiuddin M; Yokoyama H; Reiss GR; DiSesa VJ
    J Heart Lung Transplant; 1996 Oct; 15(10):1034-8. PubMed ID: 8913921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine immunoreactive thromboxane B2 in rat cardiac allograft rejection.
    Khirabadi BS; Foegh ML; Ramwell PW
    Transplantation; 1985 Jan; 39(1):6-8. PubMed ID: 3880966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of thromboxane antagonism on the transit time of platelets through the spleen.
    Peters AM; Lane IF; Sinclair M; Irwin JT; McCollum CN
    Thromb Haemost; 1985 Aug; 54(2):495-7. PubMed ID: 2934858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of cardiac allograft survival with the PAF antagonist BN-52021 and the thromboxane receptor antagonists L640035 and L636499.
    Foegh ML; Alijani MR; Helfrich GB; Khirabadi BS; Ramwell PW
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():381-4. PubMed ID: 2936126
    [No Abstract]   [Full Text] [Related]  

  • 11. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
    Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA
    J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
    Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
    J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased rat cardiac allograft survival by the glycosaminoglycan pentosan polysulfate.
    Schwartz CF; Kilgore KS; Homeister JW; Levy BA; Lucchesi BR; Bolling SF
    J Surg Res; 1999 Sep; 86(1):24-8. PubMed ID: 10452864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
    Shimomura K; Hardy MA; Oluwole SF
    Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of prostanoid-mediated platelet aggregation in vivo and in vitro by 3-hydroxymethyl-dibenzo(b,f)thiepin 5,5-dioxide (L-640,035).
    Chan CC; Nathaniel DJ; Yusko PJ; Hall RA; Ford-Hutchinson AW
    J Pharmacol Exp Ther; 1984 Apr; 229(1):276-82. PubMed ID: 6423813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism of (15 S)-15-methyl-prostaglandin E1 with either azathioprine or prednisolone on the survival of heart allografts in rats.
    Kort WJ; Bonta IL; Adolfs MJ; Westbroek DL
    Prostaglandins Leukot Med; 1982 Jun; 8(6):661-4. PubMed ID: 7051048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
    J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.